I can completely understand your frustration
@Totalwar
I think a lot of it is down to the nature of scientific research, and the way it is often analysed and interpreted to create policy and guidelines, where what is looked for is
one approach or answer to a question. So multiple studies will be examined to see ‘
if we should offer this therapy (or technology) to this group’. And a balance of all the available evidence will be sought.
But this doesn’t really help individualised person-centred care, where some things may not be suitable for all, but may be entirely appropriate for a smaller subset. I think sometimes the detail gets lost.
Test strips are a classic example. There is research that shows that they are ineffective, and actually can cause upset and distress where people either don’t understand the results, aren’t interested in them and find it painful and burdensome, or get alarmed at seeing high readings. And yet on the forum we see time and again that for the right people, with the right encouragement and support, BG monitoring can be an essential and extremely positive part of their diabetes management toolkit.
Over the years I have certainly seen positions softening, and I really hope the situation continues to improve, and that access to all sorts of tech (strips, sensors, insulin pumps etc) will be made available to the right people at the right time on a case-by-case basis, whatever their type of diabetes.